oncotherapy

oncotherapy

 [ong″ko-ther´ah-pe]
the treatment of tumors.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

on·co·ther·a·py

(ong'kō-ther'ă-pē),
Treatment of tumors.
Farlex Partner Medical Dictionary © Farlex 2012

oncotherapy

(ŏng″kō-thĕr′ă-pē) [″ + therapeia, treatment]
The treatment of tumors.
Medical Dictionary, © 2009 Farlex and Partners
References in periodicals archive ?
For instance, in December 2017, Advanced Oncotherapy plc announced that it secures the fresh funding of USD 46.75 million from which USD 37.5 million of funds coming from a new Chinese investor.
Advanced Oncotherapy PLC (LON:AVO) chief executive Nicolas Serandour said the company remained on course to treat its first patient with its next-generation proton therapy system for cancer by the end of 2020.
(Alliance News) - Advanced Oncotherapy PLC on Friday said its loss widened in 2018 as a consequence of cost of sales and higher administrative expenses.
Reportedly, the first customer of this new system will be Advanced Oncotherapy plc (AVO), a UK based developer of next generation proton therapy technology.
The remaining 32 patients had symptomatic T1 (n=18 T1S1) disease that was not responding to ART adequately and were considered for oncotherapy. Of these patients, 22 (n=9 T1S1) received additional oncological treatment (group 2).
Eisai focuses its efforts in three therapeutic areas: integrative neuroscience, including neurology and psychiatric medicines; integrative oncology, which encompasses oncotherapy and supportive-care treatments; and vascular/immunological reaction.
Most of [all] in oncotherapy, NeoBiocon has the second-largest chemotherapy brand in UAE with a market share of 31 per cent and is among the top 15 oncology companies in the UAE."
20 November 2015 - UK-based Advanced Oncotherapy Plc (AIM: AVO), a developer of proton therapy systems for cancer treatment, announces has disposed of its subsidiary, Oncotherapy Resources Ltd for a total cash consideration of GBP 100,000 (USD 152,800), the company said.
[USPRwire, Mon Oct 26 2015] Global Markets Direct's, 'OncoTherapy Science, Inc.
announces that the exclusive licensing contract that has been in effect with OncoTherapy Science, Inc.
Companies Mentioned in this Report: Hitachi, IBA Proton Therapy, Mitsubishi Electric, Varian Medical Systems, Accuray, Advanced Oncotherapy, Advanced Particle Therapy, Advanced Proton Solutions, Best Particle Therapy, Compact Particle Acceleration, Elekta, GE Healthcare, Mevion Medical Systems, Optivus ProtonTherap, Procure Treatment Center, ProNova Solutions, ProTom International, SAH Global, Siemens, Sumitomo Heavy Industries, Toshiba